Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?

Prostate cancer scanning: Photos from inside Mayo's lab

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
New imaging agent
Ping Fang, a senior chemist in Radiology at Mayo Clinic, monitors the production of C-11 methyl choline in a lab Wednesday, Nov. 28, 2012 at Mayo Clinic in Rochester, Minn. C-11 choline is an agent used during PET scans to help detect reoccurring prostate cancer. The Mayo Clinic is the only health facility in the U.S. currently approved by the FDA to administer Choline during PET scans, and they plan to expand their production and services to offer it to more patients.
MPR Photo/Jeffrey Thompson/Read the full story here

When treating cancer patients who suffer a second bout of the disease, doctors know catching the recurrence soon is crucial to the patient's chances of survival. It's especially been a challenge with prostate cancer. That's why a new Mayo Clinic scanning technique that helps doctors detect recurring prostate cancers months or even years earlier than before, is receiving considerable attention.

Gallery
11 of 11
Hugging nurse
Patient Larry Weber greets nurse Diane Mann, R.N., following his PET scan, Wednesday, Nov. 28, 2012, at Mayo Clinic in Rochester, Minn.
MPR Photo/Jeffrey Thompson/Read the full story here
1 of 11
New imaging agent
Ping Fang, a senior chemist in Radiology at Mayo Clinic, monitors the production of C-11 methyl choline in a lab Wednesday, Nov. 28, 2012 at Mayo Clinic in Rochester, Minn. C-11 choline is an agent used during PET scans to help detect reoccurring prostate cancer. The Mayo Clinic is the only health facility in the U.S. currently approved by the FDA to administer Choline during PET scans, and they plan to expand their production and services to offer it to more patients.
MPR Photo/Jeffrey Thompson/Read the full story here
2 of 11
Isolation chamber
Ping Fang, a senior chemist in Radiology at Mayo Clinic, prepares to produce C-11 choline in an isolation chamber Wednesday, Nov. 28, 2012 at Mayo Clinic in Rochester, Minn. C-11 choline, which is an agent used during PET scans to help detect reoccurring prostate cancer, is isolated because a radioactive marker is added to it to the production process.
MPR Photo/Jeffrey Thompson/Read the full story here